Arterial Infusion in the Treatment of Osteosarcoma View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

1988

AUTHORS

R. S. Benjamin , S. P. Chawla , C. Carrasco , A. K. Raymond , T. Fanning , S. Wallace , A. G. Ayala , J. Murray

ABSTRACT

Intra-arterial cis-platinum was introduced into the treatment of human cancer in 1977 in a patient with intransit metastases of malignant melanoma.(1) After an impressive response in that patient, a broad Phase II study was initiated. (2) One of the earliest patients on that study had an extensive malignant fibrous histiocytoma of the pubis with a soft-tissue mass which filled more than half the pelvis. The tumor had progressed in size despite therapy with radiation, 70 Gray, plus weekly systemic adriamycin. When she presented to us, she had extensive peripheral edema and was considered inoperable for a hemipelvectomy. We reasoned that since cis-platinum had some reported activity against osteosarcoma, malignant fibrous histiocytoma of bone might respond in a similar way, and that since the tumor was localized to the pelvis, the intra-arterial route would be optimal. The patient was treated, returned home to California, and called two weeks later to report the development of a new mass. More... »

PAGES

269-274

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-94-009-2691-2_42

DOI

http://dx.doi.org/10.1007/978-94-009-2691-2_42

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1002730640


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, M.D. Anderson Hospital & Tumor Institute, The University of Texas System Cancer Center, 1515 Holcombe, Box 77, 77030, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Medical Oncology, M.D. Anderson Hospital & Tumor Institute, The University of Texas System Cancer Center, 1515 Holcombe, Box 77, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Benjamin", 
        "givenName": "R. S.", 
        "id": "sg:person.01200333274.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200333274.18"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Chawla", 
        "givenName": "S. P.", 
        "id": "sg:person.0661314541.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661314541.57"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Carrasco", 
        "givenName": "C.", 
        "id": "sg:person.0661361305.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661361305.23"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Raymond", 
        "givenName": "A. K.", 
        "id": "sg:person.0702221445.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702221445.11"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Fanning", 
        "givenName": "T.", 
        "id": "sg:person.01177117507.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177117507.03"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Wallace", 
        "givenName": "S.", 
        "id": "sg:person.01016443113.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016443113.69"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Ayala", 
        "givenName": "A. G.", 
        "id": "sg:person.012665404577.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012665404577.97"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Murray", 
        "givenName": "J.", 
        "id": "sg:person.01064556313.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064556313.57"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1988", 
    "datePublishedReg": "1988-01-01", 
    "description": "Intra-arterial cis-platinum was introduced into the treatment of human cancer in 1977 in a patient with intransit metastases of malignant melanoma.(1) After an impressive response in that patient, a broad Phase II study was initiated. (2) One of the earliest patients on that study had an extensive malignant fibrous histiocytoma of the pubis with a soft-tissue mass which filled more than half the pelvis. The tumor had progressed in size despite therapy with radiation, 70 Gray, plus weekly systemic adriamycin. When she presented to us, she had extensive peripheral edema and was considered inoperable for a hemipelvectomy. We reasoned that since cis-platinum had some reported activity against osteosarcoma, malignant fibrous histiocytoma of bone might respond in a similar way, and that since the tumor was localized to the pelvis, the intra-arterial route would be optimal. The patient was treated, returned home to California, and called two weeks later to report the development of a new mass.", 
    "editor": [
      {
        "familyName": "Ryan", 
        "givenName": "James R.", 
        "type": "Person"
      }, 
      {
        "familyName": "Baker", 
        "givenName": "Laurence O.", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-94-009-2691-2_42", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-94-010-7714-9", 
        "978-94-009-2691-2"
      ], 
      "name": "Recent Concepts in Sarcoma Treatment", 
      "type": "Book"
    }, 
    "keywords": [
      "malignant fibrous histiocytoma", 
      "fibrous histiocytoma", 
      "broad phase II study", 
      "extensive peripheral edema", 
      "phase II study", 
      "intra-arterial route", 
      "soft tissue mass", 
      "treatment of osteosarcoma", 
      "intransit metastases", 
      "systemic Adriamycin", 
      "peripheral edema", 
      "II study", 
      "arterial infusion", 
      "early patients", 
      "malignant melanoma", 
      "impressive response", 
      "patients", 
      "human cancers", 
      "histiocytoma", 
      "osteosarcoma", 
      "tumors", 
      "pelvis", 
      "treatment", 
      "hemipelvectomy", 
      "edema", 
      "metastasis", 
      "infusion", 
      "therapy", 
      "melanoma", 
      "cancer", 
      "adriamycin", 
      "pubis", 
      "weeks", 
      "new mass", 
      "bone", 
      "study", 
      "response", 
      "mass", 
      "activity", 
      "grey", 
      "similar way", 
      "development", 
      "route", 
      "radiation", 
      "size", 
      "California", 
      "way"
    ], 
    "name": "Arterial Infusion in the Treatment of Osteosarcoma", 
    "pagination": "269-274", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1002730640"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-94-009-2691-2_42"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-94-009-2691-2_42", 
      "https://app.dimensions.ai/details/publication/pub.1002730640"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-12-01T06:48", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/chapter/chapter_185.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-94-009-2691-2_42"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-94-009-2691-2_42'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-94-009-2691-2_42'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-94-009-2691-2_42'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-94-009-2691-2_42'


 

This table displays all metadata directly associated to this object as RDF triples.

153 TRIPLES      22 PREDICATES      72 URIs      65 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-94-009-2691-2_42 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N99590e67649d461ba7a88c9b20cc1c45
4 schema:datePublished 1988
5 schema:datePublishedReg 1988-01-01
6 schema:description Intra-arterial cis-platinum was introduced into the treatment of human cancer in 1977 in a patient with intransit metastases of malignant melanoma.(1) After an impressive response in that patient, a broad Phase II study was initiated. (2) One of the earliest patients on that study had an extensive malignant fibrous histiocytoma of the pubis with a soft-tissue mass which filled more than half the pelvis. The tumor had progressed in size despite therapy with radiation, 70 Gray, plus weekly systemic adriamycin. When she presented to us, she had extensive peripheral edema and was considered inoperable for a hemipelvectomy. We reasoned that since cis-platinum had some reported activity against osteosarcoma, malignant fibrous histiocytoma of bone might respond in a similar way, and that since the tumor was localized to the pelvis, the intra-arterial route would be optimal. The patient was treated, returned home to California, and called two weeks later to report the development of a new mass.
7 schema:editor N8d8be15101764ef28636c522f9417e99
8 schema:genre chapter
9 schema:isAccessibleForFree false
10 schema:isPartOf N9491f32378c94210aa449383824bcf72
11 schema:keywords California
12 II study
13 activity
14 adriamycin
15 arterial infusion
16 bone
17 broad phase II study
18 cancer
19 development
20 early patients
21 edema
22 extensive peripheral edema
23 fibrous histiocytoma
24 grey
25 hemipelvectomy
26 histiocytoma
27 human cancers
28 impressive response
29 infusion
30 intra-arterial route
31 intransit metastases
32 malignant fibrous histiocytoma
33 malignant melanoma
34 mass
35 melanoma
36 metastasis
37 new mass
38 osteosarcoma
39 patients
40 pelvis
41 peripheral edema
42 phase II study
43 pubis
44 radiation
45 response
46 route
47 similar way
48 size
49 soft tissue mass
50 study
51 systemic Adriamycin
52 therapy
53 treatment
54 treatment of osteosarcoma
55 tumors
56 way
57 weeks
58 schema:name Arterial Infusion in the Treatment of Osteosarcoma
59 schema:pagination 269-274
60 schema:productId N133d1d80ffab4fc39bae185ed20c79c0
61 N863d815c919349e2ae94cf42383819c3
62 schema:publisher N043d9f184e65495d9243405889006bc2
63 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002730640
64 https://doi.org/10.1007/978-94-009-2691-2_42
65 schema:sdDatePublished 2022-12-01T06:48
66 schema:sdLicense https://scigraph.springernature.com/explorer/license/
67 schema:sdPublisher N37f830fd5eae4d3886d870d17205d62e
68 schema:url https://doi.org/10.1007/978-94-009-2691-2_42
69 sgo:license sg:explorer/license/
70 sgo:sdDataset chapters
71 rdf:type schema:Chapter
72 N043d9f184e65495d9243405889006bc2 schema:name Springer Nature
73 rdf:type schema:Organisation
74 N133d1d80ffab4fc39bae185ed20c79c0 schema:name dimensions_id
75 schema:value pub.1002730640
76 rdf:type schema:PropertyValue
77 N37f830fd5eae4d3886d870d17205d62e schema:name Springer Nature - SN SciGraph project
78 rdf:type schema:Organization
79 N3bbdc9c70f8d4ba1bc8cd4710c1afb87 schema:familyName Baker
80 schema:givenName Laurence O.
81 rdf:type schema:Person
82 N863d815c919349e2ae94cf42383819c3 schema:name doi
83 schema:value 10.1007/978-94-009-2691-2_42
84 rdf:type schema:PropertyValue
85 N8c1bbd9ee675461797b080440ddd0d80 rdf:first sg:person.012665404577.97
86 rdf:rest Nf01f05899d1c46f6b44df06dd49dd5b2
87 N8ca248d39fda4064a98a1815c792e5a8 rdf:first sg:person.01177117507.03
88 rdf:rest N97da9247591a4caaa88d9335f9d5f939
89 N8d8be15101764ef28636c522f9417e99 rdf:first N9f62bc3331594cf3a29f090bd56d9894
90 rdf:rest Na840d039c1b549b4bc211f9e1939822d
91 N9491f32378c94210aa449383824bcf72 schema:isbn 978-94-009-2691-2
92 978-94-010-7714-9
93 schema:name Recent Concepts in Sarcoma Treatment
94 rdf:type schema:Book
95 N97da9247591a4caaa88d9335f9d5f939 rdf:first sg:person.01016443113.69
96 rdf:rest N8c1bbd9ee675461797b080440ddd0d80
97 N99590e67649d461ba7a88c9b20cc1c45 rdf:first sg:person.01200333274.18
98 rdf:rest Nad2dd2edd64d413f8f4e112f14ce936d
99 N9f62bc3331594cf3a29f090bd56d9894 schema:familyName Ryan
100 schema:givenName James R.
101 rdf:type schema:Person
102 Na840d039c1b549b4bc211f9e1939822d rdf:first N3bbdc9c70f8d4ba1bc8cd4710c1afb87
103 rdf:rest rdf:nil
104 Nad2dd2edd64d413f8f4e112f14ce936d rdf:first sg:person.0661314541.57
105 rdf:rest Nc62b82485687455e8680d0bf3efc5604
106 Nc62b82485687455e8680d0bf3efc5604 rdf:first sg:person.0661361305.23
107 rdf:rest Ncd570b4936594f9e87d60368460338a6
108 Ncd570b4936594f9e87d60368460338a6 rdf:first sg:person.0702221445.11
109 rdf:rest N8ca248d39fda4064a98a1815c792e5a8
110 Nf01f05899d1c46f6b44df06dd49dd5b2 rdf:first sg:person.01064556313.57
111 rdf:rest rdf:nil
112 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
113 schema:name Medical and Health Sciences
114 rdf:type schema:DefinedTerm
115 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
116 schema:name Oncology and Carcinogenesis
117 rdf:type schema:DefinedTerm
118 sg:person.01016443113.69 schema:familyName Wallace
119 schema:givenName S.
120 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016443113.69
121 rdf:type schema:Person
122 sg:person.01064556313.57 schema:familyName Murray
123 schema:givenName J.
124 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064556313.57
125 rdf:type schema:Person
126 sg:person.01177117507.03 schema:familyName Fanning
127 schema:givenName T.
128 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177117507.03
129 rdf:type schema:Person
130 sg:person.01200333274.18 schema:affiliation grid-institutes:grid.240145.6
131 schema:familyName Benjamin
132 schema:givenName R. S.
133 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200333274.18
134 rdf:type schema:Person
135 sg:person.012665404577.97 schema:familyName Ayala
136 schema:givenName A. G.
137 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012665404577.97
138 rdf:type schema:Person
139 sg:person.0661314541.57 schema:familyName Chawla
140 schema:givenName S. P.
141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661314541.57
142 rdf:type schema:Person
143 sg:person.0661361305.23 schema:familyName Carrasco
144 schema:givenName C.
145 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661361305.23
146 rdf:type schema:Person
147 sg:person.0702221445.11 schema:familyName Raymond
148 schema:givenName A. K.
149 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702221445.11
150 rdf:type schema:Person
151 grid-institutes:grid.240145.6 schema:alternateName Department of Medical Oncology, M.D. Anderson Hospital & Tumor Institute, The University of Texas System Cancer Center, 1515 Holcombe, Box 77, 77030, Houston, TX, USA
152 schema:name Department of Medical Oncology, M.D. Anderson Hospital & Tumor Institute, The University of Texas System Cancer Center, 1515 Holcombe, Box 77, 77030, Houston, TX, USA
153 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...